Pieter-jan J. Cuyle

Bonheiden, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.

TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 04, 2025

Stereotactic body radiation therapy for inoperable non-metastasized pancreatic adenocarcinoma: a randomised phase II study (TORPEDO).

Stereotactic body radiation therapy for inoperable non-metastasized pancreatic adenocarcinoma: a randomised phase II study (TORPEDO).

Journal: BMC cancer

Published: September 05, 2025

Management of high-grade neuroendocrine neoplasms: impact of functional imaging.

Management of high-grade neuroendocrine neoplasms: impact of functional imaging.

Journal: Endocrine-related cancer

Published: August 31, 2024

Neuroendocrine tumors in the stomach: An epidemiological analysis of Belgian Cancer Registry data 2010-2019.

Neuroendocrine tumors in the stomach: An epidemiological analysis of Belgian Cancer Registry data 2010-2019.

Journal: Journal of neuroendocrinology

Published: June 12, 2024

Olaparib with or without bevacizumab versus bevacizumab plus a fluoropyrimidine as maintenance therapy in advanced colorectal cancer: The randomized phase 3 LYNK-003 study.

Olaparib with or without bevacizumab versus bevacizumab plus a fluoropyrimidine as maintenance therapy in advanced colorectal cancer: The randomized phase 3 LYNK-003 study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 22, 2023

Belgian guidelines for pathology reporting of neuroendocrine neoplasms of the pancreaticobiliary and gastrointestinal tract.

Belgian guidelines for pathology reporting of neuroendocrine neoplasms of the pancreaticobiliary and gastrointestinal tract.

Journal: Acta gastro-enterologica Belgica

Published: July 10, 2023

Another gastrointestinal lesion amendable for ablation.

Another gastrointestinal lesion amendable for ablation.

Journal: Acta gastro-enterologica Belgica

Published: March 19, 2022

Minimally invasive treatment of a bulging appendiceal orifice.

Minimally invasive treatment of a bulging appendiceal orifice.

Journal: Acta gastro-enterologica Belgica

Published: October 02, 2021

Lessons learned about appendiceal neuroendocrine neoplasms from data analysis of the Belgian Cancer Registry 2010-2015.

Lessons learned about appendiceal neuroendocrine neoplasms from data analysis of the Belgian Cancer Registry 2010-2015.

Journal: Acta gastro-enterologica Belgica

Published: October 02, 2021

Targeting DNA Damage Repair Mechanisms in Pancreas Cancer.

Targeting DNA Damage Repair Mechanisms in Pancreas Cancer.

Journal: Cancers

Published: July 27, 2021

68Ga-DOTATATE PET/CT Distinguishes Neuroendocrine Tumor Mesenteric Lymph Node Metastasis From an Extensive IgG4-Positive Fibrosis Surrounding It.

68Ga-DOTATATE PET/CT Distinguishes Neuroendocrine Tumor Mesenteric Lymph Node Metastasis From an Extensive IgG4-Positive Fibrosis Surrounding It.

Journal: Clinical nuclear medicine

Published: May 25, 2021

Molecular Targeting of a BRAF Mutation in Pancreatic Ductal Adenocarcinoma: Case Report and Literature Review.

Molecular Targeting of a BRAF Mutation in Pancreatic Ductal Adenocarcinoma: Case Report and Literature Review.

Journal: Targeted oncology

Published: June 05, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026